RANDAL J KIRK Insider Trading $GYHT HALOZYME THERAPEUTICS, INC.
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).
RANDAL J KIRK in HALOZYME THERAPEUTICS, INC.
Trading Symbol: GYHTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RANDAL J KIRK: 10% Owner, Director
Holdings: 4,120,689 shares
Latest Transaction: Aug 28 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RANDAL J KIRK in HALOZYME THERAPEUTICS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.02 | 256,860 | 4,628,617 | 1,897,610 | 2.2 M to 1.9 M (-11.92 %) |
Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.22 | 64,996 | 1,184,227 | 2,154,470 | 2.2 M to 2.2 M (-2.93 %) |
Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.20 | 61,428 | 1,117,990 | 2,219,466 | 2.3 M to 2.2 M (-2.69 %) |
Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.02 | 175,389 | 3,160,510 | 3,900,919 | 4.1 M to 3.9 M (-4.30 %) |
Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.22 | 44,381 | 808,622 | 4,076,308 | 4.1 M to 4.1 M (-1.08 %) |
Aug 28 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.20 | 41,944 | 763,381 | 4,120,689 | 4.2 M to 4.1 M (-1.01 %) |
Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.48 | 149,353 | 2,760,043 | 2,280,894 | 2.4 M to 2.3 M (-6.15 %) |
Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.49 | 464,624 | 8,126,274 | 2,430,247 | 2.9 M to 2.4 M (-16.05 %) |
Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.15 | 95,819 | 1,643,296 | 2,894,871 | 3 M to 2.9 M (-3.20 %) |
Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 18.48 | 101,982 | 1,884,627 | 4,162,633 | 4.3 M to 4.2 M (-2.39 %) |
Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.49 | 317,257 | 5,548,825 | 4,264,615 | 4.6 M to 4.3 M (-6.92 %) |
Aug 23 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.15 | 65,427 | 1,122,073 | 4,581,872 | 4.6 M to 4.6 M (-1.41 %) |
Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.24 | 56,668 | 976,956 | 2,985,054 | 3 M to 3 M (-1.86 %) |
Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.15 | 54,397 | 932,909 | 3,041,722 | 3.1 M to 3 M (-1.76 %) |
Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.36 | 180,154 | 3,127,473 | 3,096,119 | 3.3 M to 3.1 M (-5.50 %) |
Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.24 | 38,695 | 667,102 | 4,643,451 | 4.7 M to 4.6 M (-0.83 %) |
Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.15 | 37,144 | 637,020 | 4,682,146 | 4.7 M to 4.7 M (-0.79 %) |
Aug 16 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.36 | 123,014 | 2,135,523 | 4,719,290 | 4.8 M to 4.7 M (-2.54 %) |
Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.08 | 120,606 | 2,059,950 | 3,276,273 | 3.4 M to 3.3 M (-3.55 %) |
Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.48 | 132,591 | 2,317,691 | 3,396,879 | 3.5 M to 3.4 M (-3.76 %) |
Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.52 | 87,185 | 1,527,481 | 3,529,470 | 3.6 M to 3.5 M (-2.41 %) |
Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.08 | 82,353 | 1,406,589 | 4,842,304 | 4.9 M to 4.8 M (-1.67 %) |
Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.48 | 90,536 | 1,582,569 | 4,924,657 | 5 M to 4.9 M (-1.81 %) |
Aug 10 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.52 | 59,533 | 1,043,018 | 5,015,193 | 5.1 M to 5 M (-1.17 %) |
Jul 27 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.90 | 29,074 | 491,351 | 3,616,655 | 3.6 M to 3.6 M (-0.80 %) |
Jul 27 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.30 | 89,136 | 1,542,053 | 3,645,729 | 3.7 M to 3.6 M (-2.39 %) |
Jul 27 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.32 | 61,741 | 1,069,354 | 3,734,865 | 3.8 M to 3.7 M (-1.63 %) |
Jul 27 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.90 | 19,853 | 335,516 | 5,074,726 | 5.1 M to 5.1 M (-0.39 %) |
Jul 27 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.30 | 60,864 | 1,052,947 | 5,094,579 | 5.2 M to 5.1 M (-1.18 %) |
Jul 27 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.32 | 42,159 | 730,194 | 5,155,443 | 5.2 M to 5.2 M (-0.81 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.97 | 72,753 | 1,234,618 | 3,796,606 | 3.9 M to 3.8 M (-1.88 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.97 | 72,753 | 1,234,618 | 3,796,606 | 3.9 M to 3.8 M (-1.88 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.99 | 76,291 | 1,296,184 | 3,869,359 | 3.9 M to 3.9 M (-1.93 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.99 | 76,291 | 1,296,184 | 3,869,359 | 3.9 M to 3.9 M (-1.93 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.34 | 31,795 | 551,325 | 3,945,650 | 4 M to 3.9 M (-0.80 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.34 | 31,795 | 551,325 | 3,945,650 | 4 M to 3.9 M (-0.80 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.97 | 49,678 | 843,036 | 5,197,602 | 5.2 M to 5.2 M (-0.95 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.97 | 49,678 | 843,036 | 5,197,602 | 5.2 M to 5.2 M (-0.95 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.99 | 52,094 | 885,077 | 5,247,280 | 5.3 M to 5.2 M (-0.98 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 16.99 | 52,094 | 885,077 | 5,247,280 | 5.3 M to 5.2 M (-0.98 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.34 | 21,710 | 376,451 | 5,299,374 | 5.3 M to 5.3 M (-0.41 %) |
Jun 29 2018 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | 10% Owner | Sell | S | 17.34 | 21,710 | 376,451 | 5,299,374 | 5.3 M to 5.3 M (-0.41 %) |
Jul 26 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,327,603 | 0 | 2,327,603 | 0 to 2.3 M |
Jul 26 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,264,483 | 0 | 5,321,084 | 3.1 M to 5.3 M (+74.09 %) |
Jul 26 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Sell | J | 0.00 | 6,328,853 | 0 | 0 | 6.3 M to 0 (-100.00 %) |
May 15 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Option Exercise | M | 10.37 | 10,000 | 103,700 | 0 | |
May 15 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | M | 10.37 | 10,000 | 103,700 | 3,562,388 | 3.6 M to 3.6 M (+0.28 %) |
May 08 2017 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 14,135 | 0 | 3,552,388 | 3.5 M to 3.6 M (+0.40 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 21,858 | 0 | 21,858 | 0 to 21.9 K |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 65,572 | 0 | 65,572 | 0 to 65.6 K |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 131,144 | 0 | 131,144 | 0 to 131.1 K |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 4,382 | 0 | 46,701 | 42.3 K to 46.7 K (+10.35 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 27,260 | 0 | 290,460 | 263.2 K to 290.5 K (+10.36 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 2,235 | 0 | 2,235 | 0 to 2.2 K |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 23,259 | 0 | 354,653 | 331.4 K to 354.7 K (+7.02 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 23,259 | 0 | 354,654 | 331.4 K to 354.7 K (+7.02 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 9,954 | 0 | 302,954 | 293 K to 303 K (+3.40 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 9,954 | 0 | 302,954 | 293 K to 303 K (+3.40 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 9,954 | 0 | 302,954 | 293 K to 303 K (+3.40 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 372 | 0 | 11,317 | 10.9 K to 11.3 K (+3.40 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 371,186 | 0 | 3,056,601 | 2.7 M to 3.1 M (+13.82 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | J | 0.00 | 81,795 | 0 | 216,795 | 135 K to 216.8 K (+60.59 %) |
Jun 02 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Sell | J | 0.00 | 1,326,320 | 0 | 0 | 1.3 M to 0 (-100.00 %) |
May 05 2016 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 20,202 | 0 | 3,538,253 | 3.5 M to 3.5 M (+0.57 %) |
May 08 2015 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 13,175 | 0 | 3,518,051 | 3.5 M to 3.5 M (+0.38 %) |
Page: 1